BFLY trades 43.6% above Wall Street's consensus target of $5.19.
Last 12 months price action with 12-month analyst target path
The base valuation assumes BFLY achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 7 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 24, 2026, Butterfly Network, Inc. (BFLY) has a Wall Street consensus price target of $5.19, based on estimates from 7 covering analysts. With the stock currently trading at $9.20, this represents a potential downside of -43.6%. The company has a market capitalization of $2.45B.
Analyst price targets range from a low of $4.50 to a high of $5.50, representing a 19% spread in expectations. The median target of $5.38 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 6 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, BFLY trades at a trailing P/E of -29.7x. Analysts expect EPS to grow +58.9% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 SONOSonos, Inc. | $2.0B | $17.10 | $19.00 | +11.1% | Buy | 26.7x | 9 |
 INVAInnoviva, Inc. | $1.5B | $20.24 | $38.00 | +87.7% | Buy | 8.2x | 10 |
 AEYEAudioEye, Inc. | $89M | $7.14 | — | — | — | — | — |
 EXASExact Sciences Corporation | $20.0B | $104.91 | $92.95 | -11.4% | Buy | 582.8x | 41 |
 PRCTPROCEPT BioRobotics Corporation | $1.0B | $18.09 | $22.13 | +22.3% | Buy | — | 16 |
 EWEdwards Lifesciences Corporation | $50.0B | $86.82 | $101.70 | +17.1% | Buy | 28.9x | 49 |
 ISRGIntuitive Surgical, Inc. | $140.7B | $398.30 | $491.15 | +23.3% | Buy | 36.9x | 57 |
 HOLXHologic, Inc. | $17.0B | $76.01 | $78.69 | +3.5% | Hold | 17.2x | 42 |
 ATECAlphatec Holdings, Inc. | $1.5B | $10.03 | $16.22 | +61.7% | Buy | 30.7x | 20 |
 NVCRNovocure Ltd | $1.9B | $16.25 | $26.00 | +60.0% | Buy | — | 15 |
Quick answers to the most common questions about buying BFLY stock.
BFLY's consensus price target is $5.19, -43.6% below the current price of $9.2. The 7 analysts tracking BFLY see downside risk at present valuations.
BFLY has a consensus rating of "Buy" based on 7 Wall Street analysts. The rating breakdown is predominantly bullish, with 6 Buy/Strong Buy ratings. The consensus 12-month price target of $5.19 implies -43.6% downside from current levels.
BFLY's current price is $9.2 with a consensus target of $5.19 (-43.6% implied move). Analyst estimates suggest the stock is overvalued at current levels.
The most bullish Wall Street analyst has a price target of $5.5 for BFLY, while the most conservative target is $4.5. The consensus of $5.19 represents the median expectation. These targets typically reflect 12-month expectations.
BFLY is moderately covered, with 7 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month BFLY stock forecast based on 7 Wall Street analysts shows a consensus price target of $5.19, with estimates ranging from $4.5 (bear case) to $5.5 (bull case). The median consensus rating is "Buy".
Analysts are cautious on BFLY, with 0 Sell ratings and a price target of $5.19 (-43.6% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
BFLY analyst price targets range from $4.5 to $5.5, a 19% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $5.19 consensus represents the middle ground.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.